3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
2
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Genitourinary
1
Gastrointestinal
1
Conditions
Prostatic Neoplasms
1
Interventions
Radiotherapy
34
Gemcitabine
24
Docetaxel
24
bicalutamide
23
Goserelin
21
Paclitaxel
19
Cisplatin
19
Doxorubicin
18
Carboplatin
18
Flutamide
17
Leuprolide
16
Radiotherapy, Conformal
13
Etoposide
13
Filgrastim
12
Prednisone
11
Gene Expression Profiling
11
Gonadotropin-Releasing Hormone
10
Radiotherapy, Intensity-Modulated
9
Vincristine
8
Vinblastine
8
Triptorelin Pamoate
8
Magnetic Resonance Spectroscopy
8
Cyclophosphamide
8
Buserelin
8
Androgen Antagonists
8
Surgical Procedures, Operative
7
Radiation
7
Polymerase Chain Reaction
7
Methotrexate
7
Estramustine
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
alpha-Tocopherol
×
Genitourinary
×
Clear all
NCT00006392
2015-11-20
SELECT
SWOG Cancer Research Network
Phase 3
Completed
35,533 enrolled
20 charts